fluconazole
Generic: fluconazole
Labeler: rising pharma holdings, inc.Drug Facts
Product Profile
Brand Name
fluconazole
Generic Name
fluconazole
Labeler
rising pharma holdings, inc.
Dosage Form
POWDER, FOR SUSPENSION
Routes
Active Ingredients
fluconazole 40 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
57237-150
Product ID
57237-150_8c4429e6-5542-4bec-9d50-1021ea548c01
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA079150
Listing Expiration
2026-12-31
Marketing Start
2009-09-18
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
57237150
Hyphenated Format
57237-150
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
fluconazole (source: ndc)
Generic Name
fluconazole (source: ndc)
Application Number
ANDA079150 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 40 mg/mL
Packaging
- 1 BOTTLE in 1 CARTON (57237-150-35) / 35 mL in 1 BOTTLE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "8c4429e6-5542-4bec-9d50-1021ea548c01", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182140", "N0000182141", "N0000185504"], "unii": ["8VZV102JFY"], "rxcui": ["310352", "310353"], "spl_set_id": ["ccbe0991-27a1-4ddb-bfc7-1b3422e53390"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (57237-150-35) / 35 mL in 1 BOTTLE", "package_ndc": "57237-150-35", "marketing_start_date": "20090918"}], "brand_name": "Fluconazole", "product_id": "57237-150_8c4429e6-5542-4bec-9d50-1021ea548c01", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "57237-150", "generic_name": "Fluconazole", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fluconazole", "active_ingredients": [{"name": "FLUCONAZOLE", "strength": "40 mg/mL"}], "application_number": "ANDA079150", "marketing_category": "ANDA", "marketing_start_date": "20090918", "listing_expiration_date": "20261231"}